Latest Blogs

Mar 24, 2017
When everyone around you is telling you that you are overworked and on the verge of burnout, it's time to listen, reflect, and take action for your own well-being.
Mar 23, 2017
We may never be able to completely eliminate anxiety and stress before and after scans, yet we can definitely make a difference by confronting scanxiety upfront.
Mar 20, 2017
When the basics of cancer control are not in place, should we discuss targeted agents and immunotherapy in resource-constrained settings?
Mar 16, 2017
ASCO soundly opposes President Trump’s budget outline, which would cut $6 billion from the National Institutes of Health.
Subscribe to this column

Don S. Dizon, MD, FACP

Don S. Dizon, MD, FACP, is an Associate Professor at Harvard Medical School and is Clinical Co-Director of Gynecologic Oncology at the Massachusetts General Hospital (MGH) Cancer Center, where he also is Founder and Director of the Oncology Sexual Health Clinic. Dr. Dizon serves as Chair for ASCO's Social Media Working Group and is Immediate Past Chair of the Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which has been honored with APEX awards in 2013 and 2014, he is a blogger for MGH and a Section Editor of Gynecologic Oncology at UpToDate. Dr. Dizon is a member of the Journal of Clinical Oncology Editorial Board, and Editor in Chief of the ASCO Educational Book. Follow Dr. Dizon on Twitter @drdonsdizon.

Oct 22, 2011
I was recently interviewed about breast cancer in young women, spurred by the recent disclosure that Giuliana Rancic, of E! Entertainment News, was diagnosed with breast cancer. It struck me as...
Oct 06, 2011
I am currently sitting with colleagues from across the country as we plan the 2012 Program, an honor and yet a daunting task! Searching pubmed, vetting potential speakers, and keeping abreast on office and business matters, I rely heavily on my laptop and web access, and dating back to 1986, I have...
Sep 24, 2011
I have followed with interest the exciting progress being made across oncology--progress in melanoma with the anti-CTLA agent iplimumab and the BRAF inhibitor,...
Sep 11, 2011
I recently gave Grand Rounds at Women & Infants’ Hospital--a women’s specialty hospital that provides some of the best care for obstetrics/gynecology in the region. It is also the home to my specialized program for women with breast and gynecologic malignancies.  I spoke on delivering bad news...
Aug 14, 2011
One of the interests I have developed over time is in the arena of cancer survivorship, specifically female sexual heath after cancer and its treatment. Having worked at Memorial Sloan-Kettering both as a fellow and as a junior faculty member, I worked closely with colleagues in Gynecology,...
Jul 19, 2011
I recently returned from the semi-annual meeting of the Gynecologic Oncology Group, where the charge is to develop and test new treatment strategies in gynecologic malignancies. In the time I have been involved with the group, I have witnessed paradigm shifts in...

Pages